This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,554.48 firm fixed-price delivery order is for the procurement of 4,566,924,663 units of the contraceptive implant NEXPLANON 68 MG. The contract has an ultimate completion date of January 14, 2025 and is not associated with any set-aside designation.
DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract award is one such delivery order placed against the larger IDC vehicle, highlighting DMS Pharmaceutical Group's role as a crucial supplier in the federal pharmaceutical supply chain.
Generated 3/21/25, 9:55 AM